Guest guest Posted June 27, 2010 Report Share Posted June 27, 2010 2010/Personalized Medicine and HCV/Inhibitors - VIDEO Personalized Medicine and HCV Implications of host polymorphism IL28b for drug development and patient care - Mark Sulkowski MDMark Sulkowski, MDAssociate Professor of MedicineMedical Director, Viral Hepatitis Centers Hopkins UniversityBaltimore, land USA Reported by Jules LevinThe 5th International Workshop on Clinical Pharmacology of Hepatitis Therapy Boston, MA June 23-24, 2010 Conference Reports for NATAP http://www.natap.org/ http://Hepatitis Cnewdrugs.blogspot.com/2010/06/2010personalized-medicine-and.html Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.